Gene Therapy On Cardiovascular Disease Market Report – Research, Industry Analysis Reports and Market Demands

Global Gene Therapy On Cardiovascular Disease Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Gene Therapy On Cardiovascular Disease by Type
- 1.3.1 Overview: Global Gene Therapy On Cardiovascular Disease Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Type in 2023
- 1.3.3 Viral Gene Therapy
- 1.3.4 Non-Viral Gene Therapy
1.4 Global Gene Therapy On Cardiovascular Disease Market by Application
- 1.4.1 Overview: Global Gene Therapy On Cardiovascular Disease Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Heart Disease
- 1.4.3 Vascular Disease
1.5 Global Gene Therapy On Cardiovascular Disease Market Size & Forecast
1.6 Global Gene Therapy On Cardiovascular Disease Market Size and Forecast by Region
- 1.6.1 Global Gene Therapy On Cardiovascular Disease Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Gene Therapy On Cardiovascular Disease Market Size by Region, (2019-2030)
- 1.6.3 North America Gene Therapy On Cardiovascular Disease Market Size and Prospect (2019-2030)
- 1.6.4 Europe Gene Therapy On Cardiovascular Disease Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size and Prospect (2019-2030)
- 1.6.6 South America Gene Therapy On Cardiovascular Disease Market Size and Prospect (2019-2030)
- 1.6.7 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size and Prospect (2019-2030)

2 Company Profiles

3 Market Competition, by Players

3.1 Global Gene Therapy On Cardiovascular Disease Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Gene Therapy On Cardiovascular Disease by Company Revenue
- 3.2.2 Top 3 Gene Therapy On Cardiovascular Disease Players Market Share in 2023
- 3.2.3 Top 6 Gene Therapy On Cardiovascular Disease Players Market Share in 2023
3.3 Gene Therapy On Cardiovascular Disease Market: Overall Company Footprint Analysis
- 3.3.1 Gene Therapy On Cardiovascular Disease Market: Region Footprint
- 3.3.2 Gene Therapy On Cardiovascular Disease Market: Company Product Type Footprint
- 3.3.3 Gene Therapy On Cardiovascular Disease Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Gene Therapy On Cardiovascular Disease Consumption Value and Market Share by Type (2019-2024)
4.2 Global Gene Therapy On Cardiovascular Disease Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

5.1 Global Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Application (2019-2024)
5.2 Global Gene Therapy On Cardiovascular Disease Market Forecast by Application (2025-2030)

6 North America

6.1 North America Gene Therapy On Cardiovascular Disease Consumption Value by Type (2019-2030)
6.2 North America Gene Therapy On Cardiovascular Disease Market Size by Application (2019-2030)
6.3 North America Gene Therapy On Cardiovascular Disease Market Size by Country
- 6.3.1 North America Gene Therapy On Cardiovascular Disease Consumption Value by Country (2019-2030)
- 6.3.2 United States Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
- 6.3.3 Canada Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)

7 Europe

7.1 Europe Gene Therapy On Cardiovascular Disease Consumption Value by Type (2019-2030)
7.2 Europe Gene Therapy On Cardiovascular Disease Consumption Value by Application (2019-2030)
7.3 Europe Gene Therapy On Cardiovascular Disease Market Size by Country
- 7.3.1 Europe Gene Therapy On Cardiovascular Disease Consumption Value by Country (2019-2030)
- 7.3.2 Germany Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
- 7.3.3 France Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
- 7.3.5 Russia Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
- 7.3.6 Italy Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)

8 Asia-Pacific

8.1 Asia-Pacific Gene Therapy On Cardiovascular Disease Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Gene Therapy On Cardiovascular Disease Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size by Region
- 8.3.1 Asia-Pacific Gene Therapy On Cardiovascular Disease Consumption Value by Region (2019-2030)
- 8.3.2 China Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
- 8.3.3 Japan Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
- 8.3.5 India Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
- 8.3.7 Australia Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)

9 South America

9.1 South America Gene Therapy On Cardiovascular Disease Consumption Value by Type (2019-2030)
9.2 South America Gene Therapy On Cardiovascular Disease Consumption Value by Application (2019-2030)
9.3 South America Gene Therapy On Cardiovascular Disease Market Size by Country
- 9.3.1 South America Gene Therapy On Cardiovascular Disease Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)

10 Middle East & Africa

10.1 Middle East & Africa Gene Therapy On Cardiovascular Disease Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Gene Therapy On Cardiovascular Disease Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Country
- 10.3.1 Middle East & Africa Gene Therapy On Cardiovascular Disease Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
- 10.3.4 UAE Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)

11 Market Dynamics

11.1 Gene Therapy On Cardiovascular Disease Market Drivers
11.2 Gene Therapy On Cardiovascular Disease Market Restraints
11.3 Gene Therapy On Cardiovascular Disease Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Gene Therapy On Cardiovascular Disease Industry Chain
12.2 Gene Therapy On Cardiovascular Disease Upstream Analysis
12.3 Gene Therapy On Cardiovascular Disease Midstream Analysis
12.4 Gene Therapy On Cardiovascular Disease Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient"s cells instead of using drugs or surgery.
Although several conventional small-molecule treatments are available for common cardiovascular problems, gene therapy is a potential treatment option for acquired and inherited cardiovascular diseases that remain with unmet clinical needs.
According to our (Global Info Research) latest study, the global Gene Therapy On Cardiovascular Disease market size was valued at US$ 182 million in 2023 and is forecast to a readjusted size of USD 15030 million by 2030 with a CAGR of 88.9% during review period.
Global key players of Gene Therapy On Cardiovascular Disease include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals and Amgen, etc. Top three players occupy for a share about 76%. In terms of product, Non-Viral Gene Therapy is the largest segment, with a share over 100%. In terms of application, Vascular Disease is the largest market, with a share over 100%.
This report is a detailed and comprehensive analysis for global Gene Therapy On Cardiovascular Disease market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Gene Therapy On Cardiovascular Disease market size and forecasts, in consumption value ($ Million), 2019-2030
Global Gene Therapy On Cardiovascular Disease market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Gene Therapy On Cardiovascular Disease market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Gene Therapy On Cardiovascular Disease market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gene Therapy On Cardiovascular Disease
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gene Therapy On Cardiovascular Disease market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Gene Therapy On Cardiovascular Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Gene Therapy On Cardiovascular Disease market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Viral Gene Therapy
Non-Viral Gene Therapy
Market segment by Application
Heart Disease
Vascular Disease
Market segment by players, this report covers
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Therapy On Cardiovascular Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Therapy On Cardiovascular Disease, with revenue, gross margin, and global market share of Gene Therapy On Cardiovascular Disease from 2019 to 2024.
Chapter 3, the Gene Therapy On Cardiovascular Disease competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Gene Therapy On Cardiovascular Disease market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Therapy On Cardiovascular Disease.
Chapter 13, to describe Gene Therapy On Cardiovascular Disease research findings and conclusion.

Buy now